Clinical Trials Logo

Filter by:
NCT ID: NCT04953481 Recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

Home Care Needs and Current Nursing Status of Patients With Amyotrophic Lateral Sclerosis

Start date: January 1, 2021
Phase:
Study type: Observational

The purpose of this study is to comprehensively investigate and analyze the home care needs and status quo of ALS patients in China, and to clarify their home care needs and status quo, so as to provide reference for the development of home care service planning and policy measures for ALS patients.

NCT ID: NCT04953468 Recruiting - Glioma Clinical Trials

Expression of ANXA2 in the Extracellular Space in the Microenvironment of Periumoral Edema Promotes Glioma Invasion

Start date: February 19, 2021
Phase:
Study type: Observational

The prognostic value of ANXA2 expression in tumor tissue and PTBE was analyzed, so as to seek new therapies to inhibit glioma invasion and improve the prognosis of glioma patients

NCT ID: NCT04953260 Recruiting - Clinical trials for Chronic Periodontitis

Comparative Study of APRF/CGF Technology in GTR

Start date: August 25, 2020
Phase: N/A
Study type: Interventional

Guided tissue regeneration(GTR) uses membranous materials to shield gingival epithelial cells and connective tissue cells which grow more rapidly, creating an effective closed space and time for periodontal ligament cells with regenerative potential, so that new cementum is formed on the root surface and periodontal ligament fibers are embedded, resulting in regenerative healing. In order to improve the effect of periodontal regeneration therapy, as early as 1990s, scholars began to mix platelet concentrate and bone graft in periodontal regenerative surgery to improve the ability of local bone induction and tissue healing. Studies have shown that platelet concentrate, which is rich in a variety of growth factors in autologous blood, can promote soft tissue and bone tissue healing by acting on tissue healing cells (osteoblasts, epithelial cells, connective tissue cells, etc.). It is closely related to periodontal regeneration; the regenerative component of platelet concentrate, growth factor, and the structure of fibrin network containing growth factor are the key to promote tissue repair and regeneration.Modified platelet-rich fibrin (advanced platelet rich fibrin,APRF) and concentrated growth factor (CGF) are the latest generation of platelet concentrates. A number of studies have shown that APRF and CGF contain more cytokines, have a denser fibrin network, and show stronger ability to promote the migration and proliferation of gingival fibroblasts, suggesting that both of them may have better ability to promote bone tissue healing. At present, the latest generation of platelet concentrate has been widely used in implant surgery, but their clinical effects in periodontal regeneration surgery are still lack of conclusive evidence. there is no report on comparing the clinical effects of the two through randomized clinical controlled trials.

NCT ID: NCT04953195 Recruiting - Clinical trials for Subclinical Hypothyroidisms

Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism

Start date: January 1, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this experiment is to compared the changes of thyroid function, anti-thyroid peroxidase antibody, anti-thyroglobulin antibody, thyroid magnetic resonance T1-mapping and various metabolic indexes from baseline to the end of treatment (after the thyroid function had been normal for more than three months)

NCT ID: NCT04953117 Recruiting - Clinical trials for Coronary Artery Disease

A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease

Start date: March 10, 2021
Phase: N/A
Study type: Interventional

This study was designed to verify the safety and efficacy of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease

NCT ID: NCT04952675 Recruiting - Pneumoconiosis Clinical Trials

Evaluation of Pneumoconiosis High Risk Early Warning Models

Start date: August 1, 2018
Phase:
Study type: Observational

Precaution of pneumoconiosis is more important than treatment. However, the current process can't early warn the high-risk dust exposed workers until they are diagnosed with pneumoconiosis. With the feature of efficiency, impersonality and quantification, artificial intelligence is just appropriate for solving this problems. Therefore, we are aiming at adapting deep learning to develop models of pneumoconiosis intelligent detection, grade diagnosis and high risk early warning. The annotated images will be used for convolutional neural networks (CNNs) algorithm training, aiming at pneumoconiosis screening and grade diagnosis. Moreover, risk score calculated by density heat map will be used for early warning of dust-exposed workers. Then follow up of cohort will be implied to verify the validity of the risk score. By this way, the high-risk dust-exposed workers will get early intervention and better prognosis, which can obviously reduce medical burden.

NCT ID: NCT04952649 Recruiting - Clinical trials for Pacemaker Dependence

The Ability of Peripheral Perfusion Index To Detect Changes of Hemodynamics in Patients With Pacemaker

Start date: July 7, 2021
Phase:
Study type: Observational

Pacemakers are widely used in postcardiotomy patients to avoid severe arrhythmia. The peripheral perfusion index (PI) has been considered as an effective parameter evaluating the circulation. In this study, investigators aim to avaluate the ability of peripheral perfusion index to detect changes of hemodynamics in postcardiotomy patients with pacemakers.

NCT ID: NCT04952636 Recruiting - Clinical trials for Shoulder Dislocation

A Prospective Comparative Study of Arthroscopic and Open Surgery in Cuistow Procedure

Start date: November 6, 2021
Phase: N/A
Study type: Interventional

To evaluate the clinical outcomes of arthroscopic and open Chinese Unique Inlay Bristow procedure in treating recurrent anterior shoulder instability.

NCT ID: NCT04952493 Recruiting - Thyroid Cancer Clinical Trials

Anlotinib or Penpulimab in Combination With RAI for DTC

Start date: September 15, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of anlotinib in combination with I-131 in locally advanced/metastatic differentiated thyroid cancer. Anlotinib may stop the growth of tumor cells and improve iodine uptake.

NCT ID: NCT04952311 Recruiting - Clinical trials for Transient Ischemic Attack

Efficacy Study of Clopidogrel in High-risk Population With Acute Non-disabling Cerebrovascular Events Ⅱ

Start date: June 1, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study was to test whether ticagrelor combined with aspirin can reduce the recurrence rate of stroke within 3 months compared with clopidogrel combined with aspirin in patients at high risk of non-disablement ischemic cerebrovascular events who carry the CYP2C19 function loss allele within 24 hours of onset.